Figure 2

ICON7 randomized, double-blind, placebo-controlled phase III trial: (A) study design (B) Updated progression-free survival analysis (reproduced with permission) [[22]]. EOC = epithelial ovarian cancer. PPC = primary peritoneal cancer. FTC = fallopian tube cancer. C = Carboplatin. AUC = area under the curve. P = Paclitaxel. Bev = bevacizumab. CGIG = Gynecologic Cancer InterGroup. q3w = once every 3 weeks.